Clinical Trial Update: The Safety and Tolerability of Budesonide Foam in Participants With Active Ulcerative Proctitis or Proctosigmoiditis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and tolerability of budesonide foam in participants with active proctitis or proctosigmoiditis was terminated with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proctitis
• Proctosigmoiditis

Drugs mentioned

• budesonide foam (budesonide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Proctitis, Proctosigmoiditis | Phase 3 | Status: TERMINATED | Results posted: 2019-08-14